LifeMD, Inc. Faces Securities Investigation
LifeMD, Inc. (NASDAQ: LFMD) has recently found itself under scrutiny due to an investigation initiated by a notable securities law firm. The firm, well-regarded for representing investors’ rights, is addressing concerns surrounding potential violations of federal securities laws by LifeMD.
Identifying the Situation and Impact on Investors
The core of the issue stems from a significant announcement by LifeMD on August 5, 2025. In a statement released after market hours, the company indicated it would be revising its full-year guidance for revenue and adjusted EBITDA. This revision was attributed to what it described as temporary challenges affecting its Rex MD business.
Effects of the Company’s Announcement on Stock Performance
Following this alarming news, LifeMD's stock experienced a dramatic decline. On August 6, 2025, the stock price fell by $5.31, or a staggering 44.8%, resulting in a closing price of $6.53 per share. This sudden drop understandably left many investors feeling disillusioned and concerned about their financial futures.
What Investors Can Do
Investors who feel they have suffered losses as a result of LifeMD's recent announcements are urged to take action. There’s an opportunity for shareholders to inquire about pursuing claims to recover their losses. The investigation could pave the way for shareholders to seek justice and possibly reclaim their investments.
Contact Information for Inquiries
Those interested in participating in the ongoing investigation or who have questions regarding their rights can reach out for further information. Charles Linehan, an attorney at the forefront of this case, can be contacted for inquiries. The following details are provided for contacting him:
Charles Linehan, Esq.,
Glancy Prongay & Murray LLP,
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website: www.glancylaw.com.
What is the SEC Whistleblower Program?
In connection with the investigation, individuals with non-public information related to LifeMD may consider how they can contribute. The SEC Whistleblower Program incentivizes individuals to provide original information that can help lead to successful recoveries. Whistleblowers can earn rewards of up to 30 percent of any recovery made by the SEC as a result of their information.
About Glancy Prongay & Murray LLP
Glancy Prongay & Murray LLP is recognized as a premier law firm specializing in securities litigation and complex class actions. The firm has achieved significant results for its clients, consistently ranking highly in securities law settlements.
Final Remarks for Investors
The developments surrounding LifeMD and the ongoing investigation present crucial information for all invested parties. Investors should remain vigilant and educated about their rights, and it’s important to take action through the appropriate channels if necessary. Understanding the implications of the company’s announcements and the law firm’s investigation can guide investors toward informed decisions.
Frequently Asked Questions
What is the current status of the investigation into LifeMD?
The investigation is focused on potential violations of federal securities laws by LifeMD, with details still emerging as new information is gathered.
How did LifeMD’s stock price react to the announcement?
LifeMD's stock price plummeted by 44.8% following the announcement of revised guidance, indicating significant investor concern.
Can investors seek recovery for their losses?
Yes, investors who lost money due to LifeMD's announcements can pursue claims to recover their losses through legal avenues.
What support is available for whistleblowers?
Whistleblowers can report non-public information to the SEC and may be entitled to rewards based on the recovery amount achieved as a result of their disclosures.
Who can I contact for more details about the investigation?
For more information, interested parties can contact Charles Linehan at Glancy Prongay & Murray LLP through the provided email or phone number.
